PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8265431

Peripherally inserted central venous catheters.

M A Ryder
View original source ↗Export metadata ↓

Abstract

It has been estimated that 5 million central venous catheters are used in the United States each year. The medical market has been inundated with vascular access devices representing phenomenal advancement in catheter technology. These devices are not without serious risk, however, and they require constant vigilance and scrupulous care to prevent life-threatening complications. Nursing care and management of these devices are complex, and many controversial practice issues challenge nursing practitioners. The insertion of central venous catheters by registered nurses is a relatively new adventure in nursing practice, increasing our professional responsibility, accountability, and liability. Scientific principles and research must direct our practice and our decisions. The challenge is to seize this opportunity to develop a new concept in IV therapy based on nursing research.

Explore related subjects

Arrhythmias, CardiacArteriesCatheterization, Central VenousEmbolismEquipment DesignEquipment FailureHumansThrombosisTrauma, Nervous SystemJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M A Ryder. 1993. Peripherally inserted central venous catheters.. https://pubmed.ncbi.nlm.nih.gov/8265431/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

A maximum likelihood approach for estimating the QT correction factor using mixed effects model.

Assessment of QT interval prolongation is often used for assessing the cardiac safety of a new drug. However, the correction of the QT interval for varying heart rates has potential bias due to various different correction factors. This article proposes a maximum likelihood (ML) approach for calculating the appropriate individual correction factor using the data. The data come from a study with 24 subjects participating in a 10 day multiple dose (NEW RX) placebo-controlled cross-over trial with repeat ECGs obtained at baseline and at day 10. ML techniques were used to fit a random-effects model to observed QT and HR values for estimating the pooled and individual correction factors. QT(c) values using four correction factors (Bazett, Friderecia, pooled and individual) were investigated. The relative performance of the various correction factors are given in terms of variability and graphical techniques. The pooled correction factor was estimated to be 0.292 and the individual correction factors ranged from 0.19 to 0.41. The assessment of the treatment effect on QT(c) yielded inconsistent results. Bazett's factor indicated prolongation (6.55+/-1.20), Friderecia's factor indicated no change, while the pooled (-2.92+/-0.94) and individual (-2.82+/-1.00) factors showed a significant decrease. Graphical examination of individual QT(c) data showed a significant advantage in the use of individual correction factors versus Bazett's factor both in terms of sensitivity as well as reduction in bias. Use of individual correction factors is advocated for the assessment of possible drug-induced QT(c) prolongation.

Arrhythmias, Cardiac↗
PubMed2003

Randomised trial on the influence of continuous magnesium infusion on arrhythmias following cardiopulmonary bypass surgery for congenital heart disease.

OBJECTIVES: To check the hypothesis that continuous magnesium infusion protects the heart from arrhythmias following cardiopulmonary bypass surgery for congenital heart disease. DESIGN: A prospective randomised placebo-controlled study, with patients stratified in three weight groups. PATIENTS AND PARTICIPANTS: The study group ( n=65) postoperatively received a magnesium infusion (1 mmol/kg), the control group ( n=66) received placebo. In both groups serum and ionised magnesium values were followed, and all postoperative arrhythmias were documented for 24 h. MEASUREMENTS AND RESULTS: Serum and ionised magnesium in the blood was elevated after the end of bypass (0.54+/-0.15 mmol l(-1) pre-operatively, 0.88+/-0.24 mmol l(-1) postoperatively), where a cardioplegia solution containing magnesium was used. Magnesium values remained at this elevated level in the magnesium therapy group, and decreased to normal pre-operative values within 24 h in controls ( P<0.001). The incidence of postoperative arrhythmias was lower in the study group: 8/65 in the study group and 17/66 in the control group, respectively (chi-squared test, P=0.05). Lower patient weight (32.7 kg versus 22.6 kg), longer cardiopulmonary bypass time (128.7 min versus 87.9 min) and deeper body temperature during extracorporeal circulation (29.2 degrees C versus 32.6 degrees C) were identified as risk factors for postoperative arrhythmias ( P<0.05). CONCLUSIONS: Continuous magnesium infusion effectively reduces the rate of arrhythmias following cardiopulmonary bypass surgery for congenital heart disease and should, therefore, be routinely used.

Arrhythmias, Cardiac↗